Aficamten Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 4: 1

Top Sponsors

Oregon Health and Science University1

Indications

Hypertrophic Cardiomyopathy (HCM)1
Heart Disease1

Kansas City, Missouri1 trial

Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy

St. Luke's Hospital - Mid America Heart Institute

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.